{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:01:27Z","timestamp":1784584887997,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008454","name":"Boehringer Ingelheim Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008454","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["CRC\u2010TR128"],"award-info":[{"award-number":["CRC\u2010TR128"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["RA1739\/4\u20101"],"award-info":[{"award-number":["RA1739\/4\u20101"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"published-print":{"date-parts":[[2018,8,15]]},"DOI":"10.15252\/embj.201899429","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T09:35:24Z","timestamp":1532597724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Targeting prohibitins at the cell surface prevents Th17\u2010mediated autoimmunity"],"prefix":"10.1038","volume":"37","author":[{"given":"Ulrike","family":"Buehler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Schulenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yurugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"\u0160olman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Abankwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ulges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3034-0017","authenticated-orcid":false,"given":"Stefan","family":"Tenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Bopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1231-1928","authenticated-orcid":false,"given":"Frauke","family":"Zipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4175-9633","authenticated-orcid":false,"given":"Krishnaraj","family":"Rajalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"BFEMBJ201899429_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235\u2013238","journal-title":"Nature"},{"key":"BFEMBJ201899429_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tcb.2007.06.005","volume":"17","author":"DT Browman","year":"2007","unstructured":"Browman DT, Hoegg MB, Robbins SM (2007) The SPFH domain\u2010containing proteins: more than lipid raft markers. Trends Cell Biol 17: 394\u2013402","journal-title":"Trends Cell Biol"},{"key":"BFEMBJ201899429_CR3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1352458516658559","volume":"23","author":"U Buehler","year":"2016","unstructured":"Buehler U, Fleischer V, Luessi F, Rezk A, Belikan P, Graetz C, Gollan R, Wolf C, Lutz J, Bar\u2010Or A, Siffrin V, Zipp F (2016) Role of IL\u201017\u2010producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment. Mult Scler 23: 567\u2013576","journal-title":"Mult Scler"},{"key":"BFEMBJ201899429_CR4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/onc.2012.86","volume":"32","author":"CF Chiu","year":"2013","unstructured":"Chiu CF, Ho MY, Peng JM, Hung SW, Lee WH, Liang CM, Liang SM (2013) Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane. Oncogene 32: 777\u2013787","journal-title":"Oncogene"},{"key":"BFEMBJ201899429_CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","volume":"151","author":"M Ciofani","year":"2012","unstructured":"Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, Agarwal A, Huang W, Parkhurst CN, Muratet M, Newberry KM, Meadows S, Greenfield A, Yang Y, Jain P, Kirigin FK, Birchmeier C, Wagner EF, Murphy KM, Myers RM et\u00a0al (2012) A validated regulatory network for Th17 cell specification. Cell 151: 289\u2013303","journal-title":"Cell"},{"key":"BFEMBJ201899429_CR6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen SL, Jain R, Garg AV, Cua DJ (2014) The IL\u201023\u2010IL\u201017 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14: 585\u2013600","journal-title":"Nat Rev Immunol"},{"key":"BFEMBJ201899429_CR7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","volume":"163","author":"JT Gaublomme","year":"2015","unstructured":"Gaublomme JT, Yosef N, Lee Y, Gertner RS, Yang LV, Wu C, Pandolfi PP, Mak T, Satija R, Shalek AK, Kuchroo VK, Park H, Regev A (2015) Single\u2010cell genomics unveils critical regulators of Th17 cell pathogenicity. Cell 163: 1400\u20131412","journal-title":"Cell"},{"key":"BFEMBJ201899429_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/84443","volume":"19","author":"AG Harpur","year":"2001","unstructured":"Harpur AG, Wouters FS, Bastiaens PI (2001) Imaging FRET between spectrally similar GFP molecules in single cells. Nat Biotechnol 19: 167\u2013169","journal-title":"Nat Biotechnol"},{"key":"BFEMBJ201899429_CR9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT (2005) Interleukin 17\u2010producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123\u20131132","journal-title":"Nat Immunol"},{"key":"BFEMBJ201899429_CR10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1: 727\u2013730","journal-title":"Nat Rev Drug Discov"},{"key":"BFEMBJ201899429_CR11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/brain\/awu408","volume":"138","author":"N Hoppmann","year":"2015","unstructured":"Hoppmann N, Graetz C, Paterka M, Poisa\u2010Beiro L, Larochelle C, Hasan M, Lill CM, Zipp F, Siffrin V (2015) New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis. Brain 138: 902\u2013917","journal-title":"Brain"},{"key":"BFEMBJ201899429_CR12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature17978","volume":"534","author":"S Iwasaki","year":"2016","unstructured":"Iwasaki S, Floor SN, Ingolia NT (2016) Rocaglates convert DEAD\u2010box protein eIF4A into a sequence\u2010selective translational repressor. Nature 534: 558\u2013561","journal-title":"Nature"},{"key":"BFEMBJ201899429_CR500","doi-asserted-by":"crossref","first-page":"36401","DOI":"10.1074\/jbc.M605260200","volume":"281","author":"K Kasashima","year":"2006","unstructured":"Kasashima K, Ohta E, Kagawa Y, Endo H (2006) Mitochondrial functions and estrogen receptor\u2010dependent nuclear translocation of pleiotropic human prohibitin 2. J Biol Chem 281: 36401\u201336410","journal-title":"J Biol Chem"},{"key":"BFEMBJ201899429_CR13","first-page":"ra80","volume":"6","author":"DK Kim","year":"2013","unstructured":"Kim DK, Kim HS, Kim AR, Jang GH, Kim HW, Park YH, Kim B, Park YM, Beaven MA, Kim YM, Choi WS (2013) The scaffold protein prohibitin is required for antigen\u2010stimulated signaling in mast cells. Sci Signal 6: ra80","journal-title":"Sci Signal"},{"key":"BFEMBJ201899429_CR14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm1048","volume":"10","author":"MG Kolonin","year":"2004","unstructured":"Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W (2004) Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10: 625\u2013632","journal-title":"Nat Med"},{"key":"BFEMBJ201899429_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL\u201023 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233\u2013240","journal-title":"J Exp Med"},{"key":"BFEMBJ201899429_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cytogfr.2014.07.013","volume":"25","author":"DW Luchtman","year":"2014","unstructured":"Luchtman DW, Ellwardt E, Larochelle C, Zipp F (2014) IL\u201017 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: current and future developments. Cytokine Growth Factor Rev 25: 403\u2013413","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFEMBJ201899429_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT (2006) Transforming growth factor\u2010beta induces development of the T(H)17 lineage. Nature 441: 231\u2013234","journal-title":"Nature"},{"key":"BFEMBJ201899429_CR18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/1947601911407323","volume":"2","author":"D Matallanas","year":"2011","unstructured":"Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, von Kriegsheim A, Kolch W (2011) Raf family kinases: old dogs have learned new tricks. Genes Cancer 2: 232\u2013260","journal-title":"Genes Cancer"},{"key":"BFEMBJ201899429_CR19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd1600","volume":"3","author":"I Melnikova","year":"2004","unstructured":"Melnikova I, Golden J (2004) Targeting protein kinases. Nat Rev Drug Discov 3: 993\u2013994","journal-title":"Nat Rev Drug Discov"},{"key":"BFEMBJ201899429_CR20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1101\/gad.460708","volume":"22","author":"C Merkwirth","year":"2008","unstructured":"Merkwirth C, Dargazanli S, Tatsuta T, Geimer S, Lower B, Wunderlich FT, von Kleist\u2010Retzow JC, Waisman A, Westermann B, Langer T (2008) Prohibitins control cell proliferation and apoptosis by regulating OPA1\u2010dependent cristae morphogenesis in mitochondria. Genes Dev 22: 476\u2013488","journal-title":"Genes Dev"},{"key":"BFEMBJ201899429_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbamcr.2008.05.013","volume":"1793","author":"C Merkwirth","year":"2009","unstructured":"Merkwirth C, Langer T (2009) Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 1793: 27\u201332","journal-title":"Biochim Biophys Acta"},{"key":"BFEMBJ201899429_CR22","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1111\/j.1742-4658.2010.07809.x","volume":"277","author":"S Mishra","year":"2010","unstructured":"Mishra S, Ande SR, Nyomba BL (2010) The role of prohibitin in cell signaling. FEBS J 277: 3937\u20133946","journal-title":"FEBS J"},{"key":"BFEMBJ201899429_CR23","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.0910649107","volume":"107","author":"N Patel","year":"2010","unstructured":"Patel N, Chatterjee SK, Vrbanac V, Chung I, Mu CJ, Olsen RR, Waghorne C, Zetter BR (2010) Rescue of paclitaxel sensitivity by repression of prohibitin 1 in drug\u2010resistant cancer cells. Proc Natl Acad Sci USA 107: 2503\u20132508","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201899429_CR24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","volume":"43","author":"DD Patel","year":"2015","unstructured":"Patel DD, Kuchroo VK (2015) Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity 43: 1040\u20131051","journal-title":"Immunity"},{"key":"BFEMBJ201899429_CR501","doi-asserted-by":"crossref","first-page":"89","DOI":"10.15252\/embj.201591488","volume":"35","author":"M Paterka","year":"2016","unstructured":"Paterka M, Siffrin V, Voss JO, Werr J, Hoppmann N, Gollan R, Belikan P, Bruttger J, Birkenstock J, Jung S, Esplugues E, Yogev N, Flavell RA, Bopp T, Zipp F (2016) Gatekeeper role of brain antigen\u2010presenting CD11c+ cells in neuroinflammation. EMBO J 35: 89\u2013101","journal-title":"EMBO J"},{"key":"BFEMBJ201899429_CR25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.chembiol.2012.07.012","volume":"19","author":"G Polier","year":"2012","unstructured":"Polier G, Neumann J, Thuaud F, Ribeiro N, Gelhaus C, Schmidt H, Giaisi M, Kohler R, Muller WW, Proksch P, Leippe M, Janssen O, Desaubry L, Krammer PH, Li\u2010Weber M (2012) The natural anticancer compounds rocaglamides inhibit the Raf\u2010MEK\u2010ERK pathway by targeting prohibitin 1 and 2. Chem Biol 19: 1093\u20131104","journal-title":"Chem Biol"},{"key":"BFEMBJ201899429_CR26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ncb1283","volume":"7","author":"K Rajalingam","year":"2005","unstructured":"Rajalingam K, Wunder C, Brinkmann V, Churin Y, Hekman M, Sievers C, Rapp UR, Rudel T (2005) Prohibitin is required for Ras\u2010induced Raf\u2010MEK\u2010ERK activation and epithelial cell migration. Nat Cell Biol 7: 837\u2013843","journal-title":"Nat Cell Biol"},{"key":"BFEMBJ201899429_CR27","doi-asserted-by":"crossref","first-page":"17492","DOI":"10.1073\/pnas.0407536101","volume":"101","author":"A Sharma","year":"2004","unstructured":"Sharma A, Qadri A (2004) Vi polysaccharide of Salmonella typhi targets the\u00a0prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc Natl Acad Sci USA 101: 17492\u201317497","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBJ201899429_CR28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.immuni.2010.08.018","volume":"33","author":"V Siffrin","year":"2010","unstructured":"Siffrin V, Radbruch H, Glumm R, Niesner R, Paterka M, Herz J, Leuenberger T, Lehmann SM, Luenstedt S, Rinnenthal JL, Laube G, Luche H, Lehnardt S, Fehling HJ, Griesbeck O, Zipp F (2010) In vivo imaging of partially reversible th17 cell\u2010induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33: 424\u2013436","journal-title":"Immunity"},{"key":"BFEMBJ201899429_CR29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.autrev.2014.08.019","volume":"13","author":"RP Singh","year":"2014","unstructured":"Singh RP, Hasan S, Sharma S, Nagra S, Yamaguchi DT, Wong DT, Hahn BH, Hossain A (2014) Th17 cells in inflammation and autoimmunity. Autoimmun Rev 13: 1174\u20131181","journal-title":"Autoimmun Rev"},{"key":"BFEMBJ201899429_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL\u201017\u2010producing T cells. Immunity 24: 179\u2013189","journal-title":"Immunity"},{"key":"BFEMBJ201899429_CR31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/BOR.0b013e32835fd828","volume":"25","author":"RF van Vollenhoven","year":"2013","unstructured":"van Vollenhoven RF (2013) Small molecular compounds in development for rheumatoid arthritis. Curr Opin Rheumatol 25: 391\u2013397","journal-title":"Curr Opin Rheumatol"},{"key":"BFEMBJ201899429_CR32","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMe1201071","volume":"366","author":"A Waisman","year":"2012","unstructured":"Waisman A (2012) To be 17 again\u2013anti\u2010interleukin\u201017 treatment for psoriasis. N Engl J Med 366: 1251\u20131252","journal-title":"N Engl J Med"},{"key":"BFEMBJ201899429_CR33","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","volume":"282","author":"XO Yang","year":"2007","unstructured":"Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C (2007) STAT3 regulates cytokine\u2010mediated generation of inflammatory helper T cells. J Biol Chem 282: 9358\u20139363","journal-title":"J Biol Chem"},{"key":"BFEMBJ201899429_CR34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","volume":"28","author":"XO Yang","year":"2008","unstructured":"Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS, Watowich SS, Tian Q, Jetten AM, Dong C (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28: 29\u201339","journal-title":"Immunity"},{"key":"BFEMBJ201899429_CR35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tips.2014.07.006","volume":"35","author":"J Yang","year":"2014","unstructured":"Yang J, Sundrud MS, Skepner J, Yamagata T (2014) Targeting Th17 cells in autoimmune diseases. Trends Pharmacol Sci 35: 493\u2013500","journal-title":"Trends Pharmacol Sci"},{"key":"BFEMBJ201899429_CR36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2013.03.085","volume":"434","author":"H Yurugi","year":"2013","unstructured":"Yurugi H, Tanida S, Akita K, Ishida A, Toda M, Nakada H (2013) Prohibitins function as endogenous ligands for Siglec\u20109 and negatively regulate TCR signaling upon ligation. Biochem Biophys Res Commun 434: 376\u2013381","journal-title":"Biochem Biophys Res Commun"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embj.201899429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embj.201899429","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embj.201899429\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embj.201899429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embj.201899429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:49:21Z","timestamp":1779306561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embj.201899429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":38,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,8,15]]}},"alternative-id":["BFEMBJ201899429"],"URL":"https:\/\/doi.org\/10.15252\/embj.201899429","relation":{},"ISSN":["0261-4189","1460-2075"],"issn-type":[{"value":"0261-4189","type":"print"},{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]},"assertion":[{"value":"13 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"EMBJ201899429"}}